Back to search
FDAFDA · Food and drugs·Recall number D-0671-2026

Pemetrexed for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0834-01

Published July 15, 2026 · Recall initiated: June 24, 2026

Summary

FDA records drug Class II recall D-0671-2026, published July 15, 2026 and initiated June 24, 2026. Recalling firm: Reliance Life Sciences Private Limited; Status: Ongoing; Reported quantity: 12,000 vials; Lot: Lot, expiry: RPTL0325A Dec 31, 2027; RPTL0425A Dec 31, 2027; RPTL0624B Nov 30,2027; RPTL0625A Mar 31, 2028. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Sterility Assurance

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Reliance Life Sciences Private Limited
Distributor
Nationwide in the USA
Lot
Lot, expiry: RPTL0325A Dec 31, 2027; RPTL0425A Dec 31, 2027; RPTL0624B Nov 30,2027; RPTL0625A Mar 31, 2028
Risk classification
Class II
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was Pemetrexed for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0834-01 recalled?

Yes. FDA published recall D-0671-2026 on July 15, 2026. Reported hazard: Lack of Sterility Assurance

What should I do if I have this product?

Voluntary: Firm initiated · Letter